Notice on Convening the 4th Extraordinary General Meeting in 2025
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Notice on Convening the 4th Extraordinary General Meeting in 2025
Filed with SSE · · 5 pages · Chinese
Release
Shanghai Rightongene Biotechnology Co. Ltd. on 6ix
Earlier from Shanghai Rightongene Biotechnology
- Announcement on Implementation of Semi-annual Dividend Distribution for 2025
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
- Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License
- Announcement on Resolutions of the 5th Meeting of the 3rd Board of Supervisors
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
Later from Shanghai Rightongene Biotechnology
- Announcement on Using Self-owned Funds to Pay Funds Required for Investment Projects Financed by Raised Funds and Replacing Them with an Equal Amount of Raised Funds
- Earnings Preannouncement for 2025
- Announcement on Obtaining Government Subsidies
- Announcement on Preliminary Earnings Estimate for 2025
- Notice on Convening the 2025 Annual General Meeting
Follow Shanghai Rightongene Biotechnology into a list and get an email when it puts out news.
Follow Shanghai Rightongene Biotechnology